Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.960
+0.100 (3.50%)
At close: Mar 9, 2026, 4:00 PM EDT
2.945
-0.015 (-0.51%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Actuate Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 69 | 155 | - | - |
| Enterprise Value | 50 | 142 | - | - |
| Last Close Price | 2.86 | 7.96 | - | - |
| PB Ratio | 6.08 | 1492.25 | - | - |
| P/TBV Ratio | 6.08 | 1492.25 | - | - |
| Net Debt / Equity Ratio | -1.55 | -82.94 | 0.66 | -1.31 |
| Quick Ratio | 2.66 | 0.98 | 0.43 | 4.71 |
| Current Ratio | 2.74 | 1.05 | 0.43 | 4.71 |
| Return on Equity (ROE) | -296.04% | - | -442.40% | - |
| Return on Assets (ROA) | -95.25% | -255.41% | -132.96% | - |
| Return on Capital Employed (ROCE) | -214.80% | -4876.60% | 636.30% | -125.20% |
| Earnings Yield | -36.28% | -17.55% | - | - |
| Buyback Yield / Dilution | -418.68% | -483.48% | -18.54% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.